期刊文献+

α-突触核蛋白和硝基化α-突触核蛋白在不同年龄段食蟹猴结肠中的表达 被引量:3

Differential expressions of α-synuclein and nitrated α-synuclein in colonic in different ages of cynomolgus monkeys
下载PDF
导出
摘要 目的研究α-突触核蛋白(α-synuclein,α-syn)及硝基化α-突触核蛋白(nitratedα-synuclein,n-syn)在不同年龄段食蟹猴结肠中的表达。方法免疫组织化学方法检测α-syn和n-syn在不同年龄段食蟹猴结肠中的表达。免疫荧光双标观察α-syn和n-syn的共定位。结果α-Syn和n-syn在食蟹猴结肠中存在共定位。α-Syn和n-syn在不同年龄段食蟹猴结肠中均有表达,但α-syn和n-syn在老年食蟹猴表达量最高,在青年食蟹猴表达量最低。结论α-Syn和n-syn在食蟹猴结肠中存在共定位,且在老年猴中表达最高。 Objective To explore the expressions of α-synuclein(α-syn) and nitratedα-synuclein( n-syn) in colonic in different ages of cynomolgus monkeys. Methods Immunohis-tochemistry was applied to measure the expressions of α-syn and n-syn in colonic in different ages of cynomolgus monkeys. Double immunofluorescent labeling was used to examine the co-localization of α-syn and n-syn. Results α-Syn and n-syn were colocalized in colonic of cynomolgus monkeys. α-syn and n-syn were expressed in colonic in different ages of cynomolgus monkeys. However,α-syn and n-syn expressions were the highest in colonic of old monkeys and the lowest in colonic of young monkeys. Conclusion α-Syn and n-syn are colocolized in colonic of cynomolgus monkeys and are the highest in colonic of old cynomolgus monkeys.
出处 《首都医科大学学报》 CAS 2014年第2期214-218,共5页 Journal of Capital Medical University
基金 国家自然科学基金(81071014) 国家重点基础发展计划(973)计划(2011CB504101) 国家科技支撑计划课题(2012BAI10B03) 北京市自然科学基金(7102076) 首都卫生发展科研专项课题(首发2011-1001-01)~~
关键词 Α-突触核蛋白 硝基化α-突触核蛋白 食蟹猴 α-synuclein(α-syn) nitrated α-synuclein(n-syn) cynomolgus monkeys
  • 相关文献

参考文献20

  • 1deRijk M C,Tzourio C,Breteler M M,et al.Prevalence of parkinsonism and Parkinson's disease in Europe:the EUR-OPARKINSON Collaborative Study.European Community Concerted Action on the Epidemiology of Parkinson "s dis-ease[J].J Neurol Neurosurg Psychiatry,1997,62(1):10-15.
  • 2Marek K,Jennings D.Can we image premotor Parkinson disease? [J].Neurology,2009,72(Suppl 7):21-26.
  • 3Leenders K L,Salmon E P,Tyrrell P,et al.The nigrostri-atal dopa-minergic system assessed in vivo by positron e-mission tomography in healthy volunteer subject s and pa-tients with Parkinson' s disease[J].Arch Neurol,1990,47(12):1290-1298.
  • 4Braak H,deVos R A,Bohl J,et al.Gastric ot-synucleinimmunoreactive inclusions in Meissner' s and Auerbach' s plex-uses in cases staged for Parkinson' s disease-related brain pathology [J].Neurosci Lett,2006,396(1):67-72.
  • 5Abbott R D,Petrovitch H,White L R,et al.Frequency of bowel movements and the future risk of Parkinson' s disease [J].Neurology,2001,57(3):456-462.
  • 6Claassen D O,Josephs K A,Ahlskog J E,et al.REM sleep behavior disorder preceding other aspects of synuclei-nopathies by up to half a century[J].Neurology,2010,75(6):494-499.
  • 7Liu Y,Qiang M,Wei Y,et al.A novel molecular mecha-nism for nitrated ct-synuclein-induced cell death[J].J Mol Cell Biol,2011,3(4):239-249.
  • 8Stemberger S,Poewe W,Wenning G K,et al.Targeted o-ver expression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomicfailure [J].Exp Neurol,2010,224(2):459-464.
  • 9Jones M L.Longevity of captive mammals [J].Zool Gar-ten,1982,52:113-128.
  • 10Robine J M,Allard M.The oldest human [J].Science,1998,279(5358):1834-1835.

同被引文献24

  • 1Lin C H,Chen M L,Tai Y C,et al.Reaffirmation of GAK,but not HLA-DRA,as a Parkinson's disease susceptibility gene in a Taiwan Residents population[J].Am J Med Genet B Neuropsychiatr Genet,2013,162B(8):841-846.
  • 2Mizuta I,Takafuji K,Ando Y,et al.YY1 binds to alphasynuclein 3'-flanking region SNP and stimulates antisense noncoding RNA expression[J].J Hum Genet,2013,58(11):711-719.
  • 3Brockmann K,Schulte C,Hauser A K,et al.SNCA:major genetic modifier of age at onset of Parkinson's disease[J].Mov Disord,2013,28(9):1217-1221.
  • 4Chang C,Lang H,Geng N,et al.Exosomes of BV-2 cells induced by alpha-synuclein:important mediator of neurodegeneration in PD[J].Neurosci Lett,2013,548:190-195.
  • 5Shaltiel-Karyo R,Frenkel-Pinter M,Rockenstein E,et al.A blood-brain barrier(BBB)disrupter is also a potent alpha-synuclein(alpha-syn)aggregation inhibitor:a novel dual mechanism of mannitol for the treatment of Parkinson disease(PD)[J].J Biol Chem,2013,288(24):17579-17588.
  • 6Schulz-Schaeffer W J.The synaptic pathology ofα-synuclein aggregation in dementia with Lewy bodies,Parkinson's disease and Parkinson's disease dementia[J].Acta Neuropathol,2010,120(2):131-143.
  • 7Specht C G,Tigaret C M,Rast G F,et al.Subcellular localisation of recombinant alpha-and gamma-synuclein[J].Mol Cell Neurosci,2005,28(2):326-334.
  • 8Al-Wandi A,Ninkina N,Millership S,et al.Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice[J].Neurobiol Aging,2010,31(5):796-804.
  • 9Kirkitadze M D,Bitan G,Teplow D B.Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders:the emerging role of oligomeric assemblies[J].J Neurosci Res,2002,69(5):567-577.
  • 10Yu S,Li X,Liu G,et al.Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody[J].Neuroscience,2007,145(2):539-555.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部